Newsletter subscription & archive
Biopeople

Defensin Therapeutics ApS

Defensin Therapeutics is a Danish biopharmaceutical company spun out from Novozymes A/S in 2013. Defensin Therapeutics focuses on the development and commercialization of novel products for the treatment of diseases and conditions associated with dysregulation of the human microbiota.

Address
Cobis
Ole Maaloesvej 3
DK-2200 - Copenhagen N
Denmark

Phone: +45 25471646
Email: pno@defensintherapeutics.com
Website: https://www.defensintherapeutics.com/

Contact

Name: Peter Nordkild, MD
Position: CEO

CloseClose
What are you looking for?
By using this website, you agree to the use of cookies to give you the best user experience.
Find additional information at Cookies
Ok